Drugs interactions for Lyrica®
- 15 Major drug interactions (including ingredients like Azelastine, Clonidine, Ethanol)
- 444 Moderate drug interactions (including ingredients like Acarbose, Acetazolamide, Acetylsalicylic acid)
- 453 Minor drug interactions (including ingredients like Abacavir, Acebutolol, Aceclofenac)
912 interactions for Lyrica®Pregabalin may increase the central nervous system depressant (CNS depressant) activities of Azelastine.The risk or severity of sedation can be increased when Clonidine is combined with Pregabalin.Pregabalin may increase the central nervous system depressant (CNS depressant) activities of Ethanol.The therapeutic efficacy of Pregabalin can be decreased when used in combination with Hydroxychloroquine.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Hydroxyzine.Lefamulin may increase the QTc-prolonging activities of Pregabalin.The risk or severity of adverse effects can be increased when Pregabalin is combined with Lorazepam.The risk or severity of adverse effects can be increased when Methadone is combined with Pregabalin.The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Pregabalin is combined with Oliceridine.The risk or severity of adverse effects can be increased when Pregabalin is combined with Oxycodone.The risk or severity of bradycardia can be increased when Ponesimod is combined with Pregabalin.Pregabalin may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.Pregabalin may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.The risk or severity of QTc prolongation can be increased when Trazodone is combined with Pregabalin.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Ziprasidone.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Acarbose.The therapeutic efficacy of Acetazolamide can be increased when used in combination with Pregabalin.The risk or severity of angioedema can be increased when Pregabalin is combined with Acetylsalicylic acid.The therapeutic efficacy of Alfentanil can be increased when used in combination with Pregabalin.The therapeutic efficacy of Almotriptan can be increased when used in combination with Pregabalin.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Alogliptin.The therapeutic efficacy of Alosetron can be increased when used in combination with Pregabalin.The therapeutic efficacy of Alprazolam can be increased when used in combination with Pregabalin.The risk or severity of angioedema can be increased when Alteplase is combined with Pregabalin.Pregabalin may decrease the excretion rate of Amikacin which could result in a higher serum level.Pregabalin may increase the excretion rate of Aminophylline which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Amiodarone.The therapeutic efficacy of Amisulpride can be increased when used in combination with Pregabalin.The therapeutic efficacy of Amitriptyline can be increased when used in combination with Pregabalin.The therapeutic efficacy of Amobarbital can be increased when used in combination with Pregabalin.The therapeutic efficacy of Amoxapine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Pregabalin can be decreased when used in combination with Amphetamine.The therapeutic efficacy of Pregabalin can be decreased when used in combination with Amphotericin B.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Anagrelide.The therapeutic efficacy of Apomorphine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Aripiprazole can be increased when used in combination with Pregabalin.The therapeutic efficacy of Aripiprazole lauroxil can be increased when used in combination with Pregabalin.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Arsenic trioxide.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Artemether.The therapeutic efficacy of Articaine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Asenapine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Atracurium besylate can be increased when used in combination with Pregabalin.The risk or severity of angioedema can be increased when Pregabalin is combined with Azilsartan medoxomil.The therapeutic efficacy of Baclofen can be increased when used in combination with Pregabalin.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Bedaquiline.The risk or severity of angioedema can be increased when Pregabalin is combined with Benazepril.The risk or severity of respiratory depression can be increased when Benzhydrocodone is combined with Pregabalin.The therapeutic efficacy of Benzocaine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Benzphetamine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Benzyl alcohol can be increased when used in combination with Pregabalin.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Bexagliflozin.The therapeutic efficacy of Pregabalin can be decreased when used in combination with Borage oil.The therapeutic efficacy of Botulinum toxin type B can be increased when used in combination with Pregabalin.The therapeutic efficacy of Brexanolone can be increased when used in combination with Pregabalin.The therapeutic efficacy of Brexpiprazole can be increased when used in combination with Pregabalin.Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Pregabalin.The therapeutic efficacy of Brivaracetam can be increased when used in combination with Pregabalin.The therapeutic efficacy of Bromocriptine can be increased when used in combination with Pregabalin.Pregabalin may increase the excretion rate of Bromotheophylline which could result in a lower serum level and potentially a reduction in efficacy.The therapeutic efficacy of Brompheniramine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Bupivacaine can be increased when used in combination with Pregabalin.Pregabalin may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.The therapeutic efficacy of Bupropion can be increased when used in combination with Pregabalin.The therapeutic efficacy of Buspirone can be increased when used in combination with Pregabalin.The therapeutic efficacy of Butalbital can be increased when used in combination with Pregabalin.The risk or severity of methemoglobinemia can be increased when Pregabalin is combined with Butamben.The therapeutic efficacy of Butorphanol can be increased when used in combination with Pregabalin.The therapeutic efficacy of Cabergoline can be increased when used in combination with Pregabalin.Pregabalin may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Canagliflozin.The therapeutic efficacy of Cannabidiol can be increased when used in combination with Pregabalin.Pregabalin may decrease the excretion rate of Capreomycin which could result in a higher serum level.The risk or severity of methemoglobinemia can be increased when Pregabalin is combined with Capsaicin.The risk or severity of angioedema can be increased when Pregabalin is combined with Captopril.The therapeutic efficacy of Carbinoxamine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Cariprazine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Carisoprodol can be increased when used in combination with Pregabalin.The therapeutic efficacy of Pregabalin can be decreased when used in combination with Cefotaxime.The therapeutic efficacy of Pregabalin can be decreased when used in combination with Centella asiatica.Pregabalin may increase the bradycardic activities of Ceritinib.The therapeutic efficacy of Cetirizine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Pregabalin can be decreased when used in combination with Chlorambucil.The therapeutic efficacy of Chlordiazepoxide can be increased when used in combination with Pregabalin.The therapeutic efficacy of Chloroprocaine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Pregabalin can be decreased when used in combination with Chloroquine.The therapeutic efficacy of Chlorpheniramine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Chlorpromazine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Chlorzoxazone can be increased when used in combination with Pregabalin.The therapeutic efficacy of Cinchocaine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Cisatracurium can be increased when used in combination with Pregabalin.Pregabalin may decrease the excretion rate of Cisplatin which could result in a higher serum level.The therapeutic efficacy of Citalopram can be increased when used in combination with Pregabalin.The therapeutic efficacy of Clemastine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Clidinium can be increased when used in combination with Pregabalin.The therapeutic efficacy of Clobazam can be increased when used in combination with Pregabalin.The therapeutic efficacy of Clomipramine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Clonazepam can be increased when used in combination with Pregabalin.The therapeutic efficacy of Clorazepic acid can be increased when used in combination with Pregabalin.The therapeutic efficacy of Clozapine can be increased when used in combination with Pregabalin.The risk or severity of methemoglobinemia can be increased when Pregabalin is combined with Cocaine.The therapeutic efficacy of Codeine can be increased when used in combination with Pregabalin.Pregabalin may decrease the excretion rate of Colistin which could result in a higher serum level.The risk or severity of angioedema can be increased when Pregabalin is combined with Conjugated estrogens.Crizotinib may increase the bradycardic activities of Pregabalin.The therapeutic efficacy of Cyclobenzaprine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Pregabalin can be decreased when used in combination with Cyclosporine.The therapeutic efficacy of Cyproheptadine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Dantrolene can be increased when used in combination with Pregabalin.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Dapagliflozin.The therapeutic efficacy of Daridorexant can be increased when used in combination with Pregabalin.The therapeutic efficacy of Desflurane can be increased when used in combination with Pregabalin.The therapeutic efficacy of Desipramine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Desloratadine can be increased when used in combination with Pregabalin.The metabolism of Desogestrel can be increased when combined with Pregabalin.The therapeutic efficacy of Desvenlafaxine can be increased when used in combination with Pregabalin.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Deutetrabenazine.The therapeutic efficacy of Dexbrompheniramine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Pregabalin can be decreased when used in combination with Dexchlorpheniramine maleate.The therapeutic efficacy of Dexmedetomidine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Dexmethylphenidate can be increased when used in combination with Pregabalin.The therapeutic efficacy of Dextromethorphan can be increased when used in combination with Pregabalin.The therapeutic efficacy of Dextropropoxyphene can be increased when used in combination with Pregabalin.The therapeutic efficacy of Diazepam can be increased when used in combination with Pregabalin.The risk or severity of angioedema can be increased when Pregabalin is combined with Diclofenac.The metabolism of Dienogest can be increased when combined with Pregabalin.The therapeutic efficacy of Diethylpropion can be increased when used in combination with Pregabalin.The therapeutic efficacy of Difenoxin can be increased when used in combination with Pregabalin.Pregabalin may decrease the excretion rate of Digoxin which could result in a higher serum level.The therapeutic efficacy of Dihydrocodeine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Dihydroergotamine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Dimenhydrinate can be increased when used in combination with Pregabalin.The therapeutic efficacy of Diphenhydramine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Diphenoxylate can be increased when used in combination with Pregabalin.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Disopyramide.The therapeutic efficacy of Pregabalin can be decreased when used in combination with Disulfiram.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Dofetilide.The therapeutic efficacy of Dolasetron can be increased when used in combination with Pregabalin.The therapeutic efficacy of Donepezil can be increased when used in combination with Pregabalin.The therapeutic efficacy of Doxepin can be increased when used in combination with Pregabalin.Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Pregabalin.The therapeutic efficacy of Dronabinol can be increased when used in combination with Pregabalin.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Dronedarone.The therapeutic efficacy of Droperidol can be increased when used in combination with Pregabalin.The metabolism of Drospirenone can be increased when combined with Pregabalin.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Dulaglutide.The therapeutic efficacy of Duloxetine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Dyclonine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Efavirenz can be increased when used in combination with Pregabalin.The therapeutic efficacy of Eletriptan can be increased when used in combination with Pregabalin.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Eliglustat.The risk or severity of respiratory depression can be increased when Eluxadoline is combined with Pregabalin.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Empagliflozin.The risk or severity of angioedema can be increased when Pregabalin is combined with Enalapril.The risk or severity of angioedema can be increased when Pregabalin is combined with Enalaprilat.The risk or severity of QTc prolongation can be increased when Encorafenib is combined with Pregabalin.The therapeutic efficacy of Entacapone can be increased when used in combination with Pregabalin.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Entrectinib.The therapeutic efficacy of Epinastine can be increased when used in combination with Pregabalin.The risk or severity of angioedema can be increased when Pregabalin is combined with Eprosartan.The therapeutic efficacy of Ergotamine can be increased when used in combination with Pregabalin.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Erlotinib.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Ertugliflozin.The therapeutic efficacy of Escitalopram can be increased when used in combination with Pregabalin.The therapeutic efficacy of Esketamine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Eslicarbazepine acetate can be increased when used in combination with Pregabalin.The therapeutic efficacy of Estazolam can be increased when used in combination with Pregabalin.The metabolism of Estetrol can be increased when combined with Pregabalin.The metabolism of Estradiol can be increased when combined with Pregabalin.The metabolism of Estradiol cypionate can be increased when combined with Pregabalin.The metabolism of Estradiol valerate can be increased when combined with Pregabalin.The metabolism of Estrone sulfate can be increased when combined with Pregabalin.The therapeutic efficacy of Eszopiclone can be increased when used in combination with Pregabalin.The metabolism of Ethinylestradiol can be increased when combined with Pregabalin.The therapeutic efficacy of Ethosuximide can be increased when used in combination with Pregabalin.The therapeutic efficacy of Ethotoin can be increased when used in combination with Pregabalin.The metabolism of Ethynodiol diacetate can be increased when combined with Pregabalin.The therapeutic efficacy of Etomidate can be increased when used in combination with Pregabalin.The metabolism of Etonogestrel can be increased when combined with Pregabalin.The risk or severity of QTc prolongation and torsade de pointes can be increased when Etrasimod is combined with Pregabalin.The therapeutic efficacy of Pregabalin can be decreased when used in combination with Evening primrose oil.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Exenatide.The therapeutic efficacy of Felbamate can be increased when used in combination with Pregabalin.The therapeutic efficacy of Fenfluramine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Fentanyl can be increased when used in combination with Pregabalin.The risk or severity of adverse effects can be increased when Pregabalin is combined with Fexinidazole.The therapeutic efficacy of Flibanserin can be increased when used in combination with Pregabalin.The therapeutic efficacy of Fluoxetine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Fluphenazine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Flurazepam can be increased when used in combination with Pregabalin.The therapeutic efficacy of Fluticasone propionate can be increased when used in combination with Pregabalin.The therapeutic efficacy of Fluvoxamine can be increased when used in combination with Pregabalin.The risk or severity of angioedema can be increased when Pregabalin is combined with Fosinopril.The therapeutic efficacy of Fosphenytoin can be increased when used in combination with Pregabalin.The therapeutic efficacy of Frovatriptan can be increased when used in combination with Pregabalin.The therapeutic efficacy of Gabapentin can be increased when used in combination with Pregabalin.The therapeutic efficacy of Gabapentin enacarbil can be increased when used in combination with Pregabalin.The therapeutic efficacy of gamma-Hydroxybutyric acid can be increased when used in combination with Pregabalin.The therapeutic efficacy of Ganaxolone can be increased when used in combination with Pregabalin.The therapeutic efficacy of Pregabalin can be decreased when used in combination with Ganciclovir.Pregabalin may decrease the excretion rate of Gentamicin which could result in a higher serum level.The therapeutic efficacy of Gepirone can be increased when used in combination with Pregabalin.The risk or severity of QTc prolongation can be increased when Gepotidacin is combined with Pregabalin.The metabolism of Gestodene can be increased when combined with Pregabalin.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Givinostat.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Glasdegib.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Glimepiride.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Glipizide.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Glyburide.The therapeutic efficacy of Granisetron can be increased when used in combination with Pregabalin.The therapeutic efficacy of Guanfacine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Haloperidol can be increased when used in combination with Pregabalin.Pregabalin may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.The therapeutic efficacy of Hydromorphone can be increased when used in combination with Pregabalin.The metabolism of Hydroxyprogesterone caproate can be increased when combined with Pregabalin.The risk or severity of angioedema can be increased when Pregabalin is combined with Ibuprofen.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Ibutilide.The risk or severity of angioedema can be increased when Pregabalin is combined with Icatibant.The therapeutic efficacy of Iloperidone can be increased when used in combination with Pregabalin.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Imatinib.The therapeutic efficacy of Pregabalin can be decreased when used in combination with Imipenem.The therapeutic efficacy of Imipramine can be increased when used in combination with Pregabalin.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Inotuzumab ozogamicin.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Insulin aspart.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Insulin degludec.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Insulin detemir.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Insulin glargine.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Insulin glulisine.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Insulin human.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Insulin lispro.The therapeutic efficacy of Pregabalin can be decreased when used in combination with Iohexol.The therapeutic efficacy of Isocarboxazid can be increased when used in combination with Pregabalin.The therapeutic efficacy of Isoflurane can be increased when used in combination with Pregabalin.The therapeutic efficacy of Pregabalin can be decreased when used in combination with Isoniazid.Pregabalin may increase the vasodilatory activities of Isosorbide mononitrate.The therapeutic efficacy of Ketamine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Lasmiditan can be increased when used in combination with Pregabalin.The therapeutic efficacy of Lemborexant can be increased when used in combination with Pregabalin.The therapeutic efficacy of Levetiracetam can be increased when used in combination with Pregabalin.The therapeutic efficacy of Levocabastine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Levocetirizine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Levodopa can be increased when used in combination with Pregabalin.The risk or severity of adverse effects can be increased when Pregabalin is combined with Levomilnacipran.The metabolism of Levonorgestrel can be increased when combined with Pregabalin.The therapeutic efficacy of Levorphanol can be increased when used in combination with Pregabalin.The therapeutic efficacy of Lidocaine can be increased when used in combination with Pregabalin.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Linagliptin.The therapeutic efficacy of Pregabalin can be decreased when used in combination with Linezolid.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Liraglutide.The risk or severity of angioedema can be increased when Pregabalin is combined with Lisinopril.The therapeutic efficacy of Lithium carbonate can be increased when used in combination with Pregabalin.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Lixisenatide.The therapeutic efficacy of Lofexidine can be increased when used in combination with Pregabalin.The risk or severity of angioedema can be increased when Pregabalin is combined with Losartan.The therapeutic efficacy of Loxapine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Lumateperone can be increased when used in combination with Pregabalin.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Lumefantrine.The therapeutic efficacy of Lurasidone can be increased when used in combination with Pregabalin.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Macimorelin.The therapeutic efficacy of Pregabalin can be increased when used in combination with Magnesium sulfate.The therapeutic efficacy of Maprotiline can be increased when used in combination with Pregabalin.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Mecasermin.The therapeutic efficacy of Meclizine can be increased when used in combination with Pregabalin.The metabolism of Medroxyprogesterone acetate can be increased when combined with Pregabalin.The therapeutic efficacy of Pregabalin can be decreased when used in combination with Mefloquine.The metabolism of Megestrol acetate can be increased when combined with Pregabalin.The therapeutic efficacy of Melatonin can be increased when used in combination with Pregabalin.The risk or severity of methemoglobinemia can be increased when Pregabalin is combined with Meloxicam.The therapeutic efficacy of Meperidine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Mepivacaine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Meprobamate can be increased when used in combination with Pregabalin.The therapeutic efficacy of Mepyramine can be increased when used in combination with Pregabalin.Pregabalin may increase the excretion rate of Mercaptopurine which could result in a lower serum level and potentially a reduction in efficacy.The therapeutic efficacy of Metaxalone can be increased when used in combination with Pregabalin.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Metformin.The therapeutic efficacy of Methocarbamol can be increased when used in combination with Pregabalin.The therapeutic efficacy of Methohexital can be increased when used in combination with Pregabalin.The therapeutic efficacy of Methsuximide can be increased when used in combination with Pregabalin.The therapeutic efficacy of Methylene blue can be increased when used in combination with Pregabalin.The therapeutic efficacy of Pregabalin can be decreased when used in combination with Methylphenidate.The risk or severity of sedation can be increased when Metoclopramide is combined with Pregabalin.The therapeutic efficacy of Pregabalin can be decreased when used in combination with Metronidazole.Pregabalin may increase the sedative activities of Metyrosine.The therapeutic efficacy of Midazolam can be increased when used in combination with Pregabalin.The metabolism of Mifepristone can be increased when combined with Pregabalin.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Miglitol.The therapeutic efficacy of Milnacipran can be increased when used in combination with Pregabalin.The therapeutic efficacy of Mirtazapine can be increased when used in combination with Pregabalin.The risk or severity of angioedema can be increased when Pregabalin is combined with Moexipril.The therapeutic efficacy of Molindone can be increased when used in combination with Pregabalin.The therapeutic efficacy of Morphine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Nabilone can be increased when used in combination with Pregabalin.The therapeutic efficacy of Nalbuphine can be increased when used in combination with Pregabalin.The risk or severity of respiratory depression can be increased when Naloxegol is combined with Pregabalin.The risk or severity of respiratory depression can be increased when Naltrexone is combined with Pregabalin.The risk or severity of CNS depression can be increased when Naphazoline is combined with Pregabalin.The therapeutic efficacy of Naratriptan can be increased when used in combination with Pregabalin.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Nateglinide.The therapeutic efficacy of Nefazodone can be increased when used in combination with Pregabalin.Pregabalin may decrease the excretion rate of Neomycin which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Nilotinib.The therapeutic efficacy of Nitrous oxide can be increased when used in combination with Pregabalin.The metabolism of Nonoxynol-9 can be increased when combined with Pregabalin.The metabolism of Norelgestromin can be increased when combined with Pregabalin.The metabolism of Norethisterone can be increased when combined with Pregabalin.The metabolism of Norgestimate can be increased when combined with Pregabalin.The metabolism of Norgestrel can be increased when combined with Pregabalin.The therapeutic efficacy of Nortriptyline can be increased when used in combination with Pregabalin.The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Pregabalin.The therapeutic efficacy of Olanzapine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Ondansetron can be increased when used in combination with Pregabalin.The therapeutic efficacy of Opium can be increased when used in combination with Pregabalin.Orlistat can cause a decrease in the absorption of Pregabalin resulting in a reduced serum concentration and potentially a decrease in efficacy.The therapeutic efficacy of Orphenadrine can be increased when used in combination with Pregabalin.The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Pregabalin.The therapeutic efficacy of Oxazepam can be increased when used in combination with Pregabalin.The therapeutic efficacy of Oxcarbazepine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Oxybuprocaine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Oxymorphone can be increased when used in combination with Pregabalin.The therapeutic efficacy of Paliperidone can be increased when used in combination with Pregabalin.The therapeutic efficacy of Palonosetron can be increased when used in combination with Pregabalin.The therapeutic efficacy of Pancuronium can be increased when used in combination with Pregabalin.The therapeutic efficacy of Paroxetine can be increased when used in combination with Pregabalin.Pregabalin may decrease the excretion rate of Pemetrexed which could result in a higher serum level.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Pentamidine.The therapeutic efficacy of Pentazocine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Pentobarbital can be increased when used in combination with Pregabalin.Pregabalin may decrease the excretion rate of Pentostatin which could result in a higher serum level.Pregabalin may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.The therapeutic efficacy of Perampanel can be increased when used in combination with Pregabalin.The therapeutic efficacy of Pergolide can be increased when used in combination with Pregabalin.The risk or severity of angioedema can be increased when Pregabalin is combined with Perindopril.The therapeutic efficacy of Perphenazine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Phenelzine can be increased when used in combination with Pregabalin.The risk or severity of methemoglobinemia can be increased when Pregabalin is combined with Phenol.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Pimavanserin.The therapeutic efficacy of Pimozide can be increased when used in combination with Pregabalin.The therapeutic efficacy of Pindolol can be increased when used in combination with Pregabalin.Pregabalin may increase the QTc-prolonging activities of Pitolisant.Pregabalin may decrease the excretion rate of Plazomicin which could result in a higher serum level.The therapeutic efficacy of Pomalidomide can be increased when used in combination with Pregabalin.Pregabalin may increase the sedative activities of Pramipexole.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Pramlintide.The therapeutic efficacy of Pramocaine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Prilocaine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Primidone can be increased when used in combination with Pregabalin.Pregabalin may decrease the excretion rate of Procainamide which could result in a higher serum level.The therapeutic efficacy of Procaine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Procarbazine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Prochlorperazine can be increased when used in combination with Pregabalin.The metabolism of Progesterone can be increased when combined with Pregabalin.The therapeutic efficacy of Promethazine can be increased when used in combination with Pregabalin.The risk or severity of methemoglobinemia can be increased when Pregabalin is combined with Proparacaine.The therapeutic efficacy of Propofol can be increased when used in combination with Pregabalin.The therapeutic efficacy of Protriptyline can be increased when used in combination with Pregabalin.The therapeutic efficacy of Pyrantel can be increased when used in combination with Pregabalin.The therapeutic efficacy of Quazepam can be increased when used in combination with Pregabalin.The therapeutic efficacy of Quetiapine can be increased when used in combination with Pregabalin.The risk or severity of angioedema can be increased when Pregabalin is combined with Quinapril.Pregabalin may decrease the excretion rate of Quinidine which could result in a higher serum level.The therapeutic efficacy of Quinine can be increased when used in combination with Pregabalin.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Quizartinib.The therapeutic efficacy of Ramelteon can be increased when used in combination with Pregabalin.The risk or severity of angioedema can be increased when Ramipril is combined with Pregabalin.The therapeutic efficacy of Rasagiline can be increased when used in combination with Pregabalin.The therapeutic efficacy of Remifentanil can be increased when used in combination with Pregabalin.The therapeutic efficacy of Remimazolam can be increased when used in combination with Pregabalin.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Repaglinide.The therapeutic efficacy of Reserpine can be increased when used in combination with Pregabalin.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Revumenib.The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Pregabalin.The therapeutic efficacy of Riluzole can be increased when used in combination with Pregabalin.The therapeutic efficacy of Risperidone can be increased when used in combination with Pregabalin.The therapeutic efficacy of Rocuronium can be increased when used in combination with Pregabalin.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Romidepsin.The risk or severity of neuropsychiatric effects can be increased when Ropeginterferon alfa-2b is combined with Pregabalin.Pregabalin may increase the sedative activities of Ropinirole.The therapeutic efficacy of Ropivacaine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Rotigotine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Rufinamide can be increased when used in combination with Pregabalin.Ruxolitinib may increase the bradycardic activities of Pregabalin.The risk or severity of angioedema can be increased when Pregabalin is combined with Sacubitril.The therapeutic efficacy of Safinamide can be increased when used in combination with Pregabalin.The therapeutic efficacy of Pregabalin can be decreased when used in combination with Sage oil.The therapeutic efficacy of Samidorphan can be increased when used in combination with Pregabalin.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Saxagliptin.The therapeutic efficacy of Scopolamine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Secobarbital can be increased when used in combination with Pregabalin.The metabolism of Segesterone acetate can be increased when combined with Pregabalin.The therapeutic efficacy of Selegiline can be increased when used in combination with Pregabalin.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Semaglutide.The therapeutic efficacy of Sertraline can be increased when used in combination with Pregabalin.The therapeutic efficacy of Sevoflurane can be increased when used in combination with Pregabalin.The risk or severity of angioedema can be increased when Pregabalin is combined with Sirolimus.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Sitagliptin.The therapeutic efficacy of Pregabalin can be decreased when used in combination with Sodium phosphate, monobasic.The therapeutic efficacy of Solriamfetol can be increased when used in combination with Pregabalin.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Sotagliflozin.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Sotalol.The therapeutic efficacy of Stiripentol can be increased when used in combination with Pregabalin.Pregabalin may decrease the excretion rate of Streptomycin which could result in a higher serum level.The therapeutic efficacy of Succinylcholine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Sufentanil can be increased when used in combination with Pregabalin.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Sulfadiazine.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Sulfamethoxazole.The therapeutic efficacy of Sumatriptan can be increased when used in combination with Pregabalin.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Sunitinib.Pregabalin may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Pregabalin.The therapeutic efficacy of Tasimelteon can be increased when used in combination with Pregabalin.The risk or severity of angioedema can be increased when Pregabalin is combined with Telmisartan.The therapeutic efficacy of Temazepam can be increased when used in combination with Pregabalin.The risk or severity of angioedema can be increased when Pregabalin is combined with Temsirolimus.The risk or severity of angioedema can be increased when Tenecteplase is combined with Pregabalin.The serum concentration of Tenofovir alafenamide can be decreased when it is combined with Pregabalin.The metabolism of Testosterone enanthate can be increased when combined with Pregabalin.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Tetrabenazine.The therapeutic efficacy of Tetracaine can be increased when used in combination with Pregabalin.The risk or severity of liver damage can be increased when Tetracosactide is combined with Pregabalin.Pregabalin may increase the excretion rate of Theophylline which could result in a lower serum level and potentially a reduction in efficacy.The therapeutic efficacy of Thioridazine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Thiothixene can be increased when used in combination with Pregabalin.The therapeutic efficacy of Tiagabine can be increased when used in combination with Pregabalin.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Tirzepatide.The therapeutic efficacy of Tizanidine can be increased when used in combination with Pregabalin.Pregabalin may decrease the excretion rate of Tobramycin which could result in a higher serum level.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Tolazamide.The therapeutic efficacy of Tolcapone can be increased when used in combination with Pregabalin.Pregabalin may increase the excretion rate of Topotecan which could result in a lower serum level and potentially a reduction in efficacy.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Toremifene.The risk or severity of angioedema can be increased when Pregabalin is combined with Trandolapril.The therapeutic efficacy of Tranylcypromine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Triazolam can be increased when used in combination with Pregabalin.The therapeutic efficacy of Trifluoperazine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Trimethobenzamide can be increased when used in combination with Pregabalin.The therapeutic efficacy of Trimipramine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Triprolidine can be increased when used in combination with Pregabalin.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Trovafloxacin.The therapeutic efficacy of Tryptophan can be increased when used in combination with Pregabalin.The metabolism of Ulipristal can be increased when combined with Pregabalin.The risk or severity of angioedema can be increased when Urokinase is combined with Pregabalin.The therapeutic efficacy of Pregabalin can be decreased when used in combination with Valganciclovir.The risk or severity of angioedema can be increased when Valsartan is combined with Pregabalin.Pregabalin may decrease the excretion rate of Vancomycin which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Vandetanib.The therapeutic efficacy of Vecuronium can be increased when used in combination with Pregabalin.The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Pregabalin.The therapeutic efficacy of Venlafaxine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Vigabatrin can be increased when used in combination with Pregabalin.The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Pregabalin.The therapeutic efficacy of Vilazodone can be increased when used in combination with Pregabalin.The therapeutic efficacy of Viloxazine can be increased when used in combination with Pregabalin.The therapeutic efficacy of Vortioxetine can be increased when used in combination with Pregabalin.Pregabalin may decrease the excretion rate of Warfarin which could result in a higher serum level.The therapeutic efficacy of Zaleplon can be increased when used in combination with Pregabalin.The therapeutic efficacy of Ziconotide can be increased when used in combination with Pregabalin.The therapeutic efficacy of Zolmitriptan can be increased when used in combination with Pregabalin.Pregabalin may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.The therapeutic efficacy of Zonisamide can be increased when used in combination with Pregabalin.The therapeutic efficacy of Zuranolone can be increased when used in combination with Pregabalin.Pregabalin may decrease the excretion rate of Abacavir which could result in a higher serum level.Pregabalin may increase the bradycardic activities of Acebutolol.Aceclofenac may decrease the excretion rate of Pregabalin which could result in a higher serum level.Pregabalin may decrease the excretion rate of Acetaminophen which could result in a higher serum level.Pregabalin may decrease the excretion rate of Aclidinium which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Acrivastine.Acyclovir may decrease the excretion rate of Pregabalin which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Adagrasib.Adefovir dipivoxil may decrease the excretion rate of Pregabalin which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Adenosine.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Salbutamol.Pregabalin may decrease the excretion rate of Albutrepenonacog alfa which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Alcaftadine.Aldesleukin may decrease the excretion rate of Pregabalin which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Alfuzosin.Pregabalin may decrease the excretion rate of Allopurinol which could result in a higher serum level.Pregabalin may decrease the excretion rate of Almasilate which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Amantadine.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Amifampridine.Amiloride may increase the excretion rate of Pregabalin which could result in a lower serum level and potentially a reduction in efficacy.Pregabalin may increase the bradycardic activities of Amlodipine.Pregabalin may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.Pregabalin may decrease the excretion rate of Amoxicillin which could result in a higher serum level.Pregabalin may decrease the excretion rate of Ampicillin which could result in a higher serum level.Antipyrine may decrease the excretion rate of Pregabalin which could result in a higher serum level.Pregabalin may decrease the excretion rate of Antithrombin III human which could result in a higher serum level.Pregabalin may decrease the excretion rate of Apalutamide which could result in a higher serum level.Pregabalin may decrease the excretion rate of Apremilast which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Arformoterol.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Atazanavir.Pregabalin may increase the bradycardic activities of Atenolol.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Atomoxetine.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Atropine.Pregabalin may decrease the excretion rate of Auranofin which could result in a higher serum level.Pregabalin may decrease the excretion rate of Azacitidine which could result in a higher serum level.Pregabalin may decrease the excretion rate of Azathioprine which could result in a higher serum level.Pregabalin may decrease the excretion rate of Azelaic acid which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Azithromycin.Pregabalin may decrease the excretion rate of Aztreonam which could result in a higher serum level.Bacitracin may decrease the excretion rate of Pregabalin which could result in a higher serum level.Balsalazide may decrease the excretion rate of Pregabalin which could result in a higher serum level.Pregabalin may decrease the excretion rate of Baricitinib which could result in a higher serum level.Pregabalin may increase the bradycardic activities of Bendroflumethiazide.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Benzatropine.Pregabalin may increase the bradycardic activities of Benzgalantamine.Pregabalin may decrease the excretion rate of Benznidazole which could result in a higher serum level.Pregabalin may decrease the excretion rate of Bepotastine which could result in a higher serum level.Pregabalin may increase the bradycardic activities of Beractant.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Berotralstat.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Besifloxacin.Betaxolol may increase the bradycardic activities of Pregabalin.Pregabalin may decrease the excretion rate of Bicisate which could result in a higher serum level.Pregabalin may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.Pregabalin may increase the bradycardic activities of Bisoprolol.Pregabalin may decrease the excretion rate of Bleomycin which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Pregabalin.Pregabalin may increase the bradycardic activities of Bretylium.Pregabalin may decrease the excretion rate of Budesonide which could result in a higher serum level.Bumetanide may decrease the excretion rate of Pregabalin which could result in a higher serum level.Pregabalin may increase the bradycardic activities of Calfactant.Pregabalin may decrease the excretion rate of Capecitabine which could result in a higher serum level.Carbidopa may decrease the excretion rate of Pregabalin which could result in a higher serum level.Carboplatin may decrease the excretion rate of Pregabalin which could result in a higher serum level.Pregabalin may decrease the excretion rate of Carmustine which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Carteolol.Pregabalin may increase the bradycardic activities of Carvedilol.Cefaclor may decrease the excretion rate of Pregabalin which could result in a higher serum level.Cefadroxil may decrease the excretion rate of Pregabalin which could result in a higher serum level.Cefazolin may decrease the excretion rate of Pregabalin which could result in a higher serum level.Pregabalin may decrease the excretion rate of Cefdinir which could result in a higher serum level.Cefditoren may decrease the excretion rate of Pregabalin which could result in a higher serum level.Cefepime may decrease the excretion rate of Pregabalin which could result in a higher serum level.Cefotetan may decrease the excretion rate of Pregabalin which could result in a higher serum level.Cefoxitin may decrease the excretion rate of Pregabalin which could result in a higher serum level.Cefpodoxime may decrease the excretion rate of Pregabalin which could result in a higher serum level.Cefprozil may decrease the excretion rate of Pregabalin which could result in a higher serum level.Ceftaroline fosamil may decrease the excretion rate of Pregabalin which could result in a higher serum level.Ceftazidime may decrease the excretion rate of Pregabalin which could result in a higher serum level.Ceftibuten may decrease the excretion rate of Pregabalin which could result in a higher serum level.Ceftizoxime may decrease the excretion rate of Pregabalin which could result in a higher serum level.Pregabalin may decrease the excretion rate of Ceftolozane which could result in a higher serum level.Ceftriaxone may decrease the excretion rate of Pregabalin which could result in a higher serum level.Cefuroxime may decrease the excretion rate of Pregabalin which could result in a higher serum level.Celecoxib may decrease the excretion rate of Pregabalin which could result in a higher serum level.Cephalexin may decrease the excretion rate of Pregabalin which could result in a higher serum level.Pregabalin may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.Cevimeline may decrease the excretion rate of Pregabalin which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Chlorcyclizine.Chlorothiazide may increase the excretion rate of Pregabalin which could result in a lower serum level and potentially a reduction in efficacy.Chlorthalidone may increase the excretion rate of Pregabalin which could result in a lower serum level and potentially a reduction in efficacy.Pregabalin may decrease the excretion rate of Choline salicylate which could result in a higher serum level.Pregabalin may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.Pregabalin may decrease the excretion rate of Chromic chloride which could result in a higher serum level.Pregabalin may decrease the excretion rate of Chromium which could result in a higher serum level.Pregabalin may decrease the excretion rate of Chromium nicotinate which could result in a higher serum level.Cidofovir may decrease the excretion rate of Pregabalin which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Cilostazol.Pregabalin may decrease the excretion rate of Cimetidine which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Ciprofloxacin.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Clarithromycin.Pregabalin may increase the bradycardic activities of Clevidipine.Pregabalin may decrease the excretion rate of Clofarabine which could result in a higher serum level.Pregabalin may decrease the excretion rate of Clove oil which could result in a higher serum level.Pregabalin may decrease the excretion rate of Colchicine which could result in a higher serum level.Colistimethate may decrease the excretion rate of Pregabalin which could result in a higher serum level.Conivaptan may increase the excretion rate of Pregabalin which could result in a lower serum level and potentially a reduction in efficacy.Pregabalin may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Dabrafenib.Pregabalin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.Pregabalin may decrease the excretion rate of Dalfampridine which could result in a higher serum level.Daptomycin may decrease the excretion rate of Pregabalin which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Dasatinib.Pregabalin may increase the neuromuscular blocking activities of DaxibotulinumtoxinA.Pregabalin may decrease the excretion rate of Deferiprone which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Degarelix.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Delafloxacin.Desmopressin may decrease the excretion rate of Pregabalin which could result in a higher serum level.Pregabalin may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.Pregabalin may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.Pregabalin may decrease the excretion rate of Dextran which could result in a higher serum level.Pregabalin may decrease the excretion rate of Diatrizoate which could result in a higher serum level.Diclofenamide may increase the excretion rate of Pregabalin which could result in a lower serum level and potentially a reduction in efficacy.Pregabalin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.Pregabalin may decrease the excretion rate of Didanosine which could result in a higher serum level.Diflunisal may decrease the excretion rate of Pregabalin which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Diltiazem.Pregabalin may decrease the excretion rate of Dimercaprol which could result in a higher serum level.Pregabalin may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.Pregabalin may decrease the excretion rate of DL-Methylephedrine which could result in a higher serum level.Pregabalin may decrease the excretion rate of Dobutamine which could result in a higher serum level.Pregabalin may decrease the excretion rate of Dopamine which could result in a higher serum level.Pregabalin may decrease the excretion rate of Doxycycline which could result in a higher serum level.Pregabalin may decrease the excretion rate of Droxidopa which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Echothiophate.Pregabalin may decrease the excretion rate of Edoxaban which could result in a higher serum level.Pregabalin may decrease the excretion rate of Edrophonium which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Emedastine.Pregabalin may decrease the excretion rate of Enzalutamide which could result in a higher serum level.Eplerenone may increase the excretion rate of Pregabalin which could result in a lower serum level and potentially a reduction in efficacy.Pregabalin may decrease the excretion rate of Epoprostenol which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Eribulin.Pregabalin may decrease the excretion rate of Ertapenem which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Erythromycin.Esmolol may increase the bradycardic activities of Pregabalin.Pregabalin may decrease the excretion rate of Estradiol acetate which could result in a higher serum level.Etacrynic acid may decrease the excretion rate of Pregabalin which could result in a higher serum level.Pregabalin may decrease the excretion rate of Ethambutol which could result in a higher serum level.Ethenzamide may decrease the excretion rate of Pregabalin which could result in a higher serum level.Etodolac may decrease the excretion rate of Pregabalin which could result in a higher serum level.Pregabalin may decrease the excretion rate of Eucalyptus oil which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Famotidine.Pregabalin may increase the bradycardic activities of Felodipine.Pregabalin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.Pregabalin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.Pregabalin may decrease the excretion rate of Fenoldopam which could result in a higher serum level.Fenoprofen may decrease the excretion rate of Pregabalin which could result in a higher serum level.Pregabalin may decrease the excretion rate of Fesoterodine which could result in a higher serum level.Finerenone may increase the excretion rate of Pregabalin which could result in a lower serum level and potentially a reduction in efficacy.Pregabalin may increase the bradycardic activities of Fingolimod.Pregabalin may decrease the excretion rate of Flavoxate which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Flecainide.Pregabalin may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.Pregabalin may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.Pregabalin may decrease the excretion rate of Floxuridine which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Pregabalin.Pregabalin may decrease the excretion rate of Flucytosine which could result in a higher serum level.Pregabalin may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.Pregabalin may decrease the excretion rate of Flumazenil which could result in a higher serum level.Pregabalin may decrease the excretion rate of Fluocinolone acetonide which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Fluorouracil.Flurbiprofen may decrease the excretion rate of Pregabalin which could result in a higher serum level.Pregabalin may decrease the excretion rate of Flutamide which could result in a higher serum level.Folic acid may decrease the excretion rate of Pregabalin which could result in a higher serum level.Pregabalin may decrease the excretion rate of Fomepizole which could result in a higher serum level.Pregabalin may decrease the excretion rate of Fondaparinux which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Formoterol.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Foscarnet.Pregabalin may decrease the excretion rate of Fosfomycin which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Fostemsavir.Furosemide may decrease the excretion rate of Pregabalin which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Gadobenic acid.Gadodiamide may decrease the excretion rate of Pregabalin which could result in a higher serum level.Pregabalin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.Pregabalin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.Pregabalin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.Pregabalin may increase the bradycardic activities of Galantamine.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Gatifloxacin.Pregabalin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.Pregabalin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Gemifloxacin.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Gilteritinib.Givosiran may decrease the excretion rate of Pregabalin which could result in a higher serum level.Pregabalin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.Pregabalin may decrease the excretion rate of Golodirsen which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Goserelin.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Histrelin.Pregabalin may decrease the excretion rate of Hydralazine which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Hydrochlorothiazide.Hydroflumethiazide may increase the excretion rate of Pregabalin which could result in a lower serum level and potentially a reduction in efficacy.Hydroxocobalamin may decrease the excretion rate of Pregabalin which could result in a higher serum level.Pregabalin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Hyoscyamine.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Ibandronate.Icosapent may decrease the excretion rate of Pregabalin which could result in a higher serum level.Pregabalin may decrease the excretion rate of Idarucizumab which could result in a higher serum level.Pregabalin may decrease the excretion rate of Ifosfamide which could result in a higher serum level.Iloprost may increase the hypotensive activities of Pregabalin.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Indapamide.Pregabalin may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Indomethacin.Pregabalin may decrease the excretion rate of Inositol which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Inotersen.Pregabalin may decrease the excretion rate of Iobenguane sulfate I-123 which could result in a higher serum level.Pregabalin may decrease the excretion rate of Iodixanol which could result in a higher serum level.Pregabalin may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.Pregabalin may decrease the excretion rate of Iopromide which could result in a higher serum level.Pregabalin may decrease the excretion rate of Iothalamic acid which could result in a higher serum level.Pregabalin may decrease the excretion rate of Ioversol which could result in a higher serum level.Pregabalin may decrease the excretion rate of Ipecac which could result in a higher serum level.Pregabalin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.Isosorbide may increase the excretion rate of Pregabalin which could result in a lower serum level and potentially a reduction in efficacy.Pregabalin may decrease the excretion rate of Isosulfan blue which could result in a higher serum level.Pregabalin may decrease the excretion rate of Isotretinoin which could result in a higher serum level.Pregabalin may increase the bradycardic activities of Isradipine.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Itraconazole.Pregabalin may increase the bradycardic activities of Ivabradine.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Ivosidenib.Pregabalin may decrease the excretion rate of Ixazomib which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Ketoconazole.Ketoprofen may decrease the excretion rate of Pregabalin which could result in a higher serum level.Ketorolac may decrease the excretion rate of Pregabalin which could result in a higher serum level.Pregabalin may increase the bradycardic activities of Labetalol.The risk or severity of ventricular arrhythmias, bradycardia, and heart block can be increased when Pregabalin is combined with Lacosamide.Pregabalin may decrease the excretion rate of Lamivudine which could result in a higher serum level.Pregabalin may increase the bradycardic activities of Landiolol.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Lanreotide.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Lapatinib.Pregabalin may decrease the excretion rate of Ledipasvir which could result in a higher serum level.Pregabalin may decrease the excretion rate of Lenalidomide which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Lenvatinib.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Leuprolide.Pregabalin may decrease the excretion rate of Levocarnitine which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Levofloxacin.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Levoketoconazole.Pregabalin may increase the bradycardic activities of Levomenthol.Pregabalin may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.Pregabalin may decrease the excretion rate of Liothyronine which could result in a higher serum level.The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Pregabalin.Lithium citrate may decrease the excretion rate of Pregabalin which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Lomefloxacin.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Loperamide.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Lopinavir.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Loratadine.Pregabalin may decrease the excretion rate of Lubiprostone which could result in a higher serum level.Pregabalin may decrease the excretion rate of Macitentan which could result in a higher serum level.Pregabalin may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.Pregabalin may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.Pregabalin may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.Magnesium salicylate may decrease the excretion rate of Pregabalin which could result in a higher serum level.Pregabalin may decrease the excretion rate of Magnesium trisilicate which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Malathion.Mannitol may decrease the excretion rate of Pregabalin which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Mavorixafor is combined with Pregabalin.Pregabalin may decrease the excretion rate of Mecamylamine which could result in a higher serum level.Meclofenamic acid may decrease the excretion rate of Pregabalin which could result in a higher serum level.Mefenamic acid may decrease the excretion rate of Pregabalin which could result in a higher serum level.Pregabalin may decrease the excretion rate of Memantine which could result in a higher serum level.Pregabalin may decrease the excretion rate of Meropenem which could result in a higher serum level.Mesalazine may decrease the excretion rate of Pregabalin which could result in a higher serum level.Pregabalin may decrease the excretion rate of Metamfetamine which could result in a higher serum level.Methazolamide may increase the excretion rate of Pregabalin which could result in a lower serum level and potentially a reduction in efficacy.Pregabalin may decrease the excretion rate of Methimazole which could result in a higher serum level.Methotrexate may decrease the excretion rate of Pregabalin which could result in a higher serum level.Pregabalin may decrease the excretion rate of Methoxsalen which could result in a higher serum level.Pregabalin may increase the bradycardic activities of Methyldopa.Pregabalin may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.Pregabalin may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.Pregabalin may decrease the excretion rate of Metolazone which could result in a higher serum level.Pregabalin may increase the bradycardic activities of Metoprolol.Pregabalin may decrease the excretion rate of Metyrapone which could result in a higher serum level.Midodrine may increase the bradycardic activities of Pregabalin.Pregabalin may decrease the excretion rate of Migalastat which could result in a higher serum level.Pregabalin may decrease the excretion rate of Milrinone which could result in a higher serum level.Minocycline may increase the central nervous system depressant (CNS depressant) activities of Pregabalin.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Mirabegron.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Moxifloxacin.Pregabalin may decrease the excretion rate of Mycophenolate mofetil which could result in a higher serum level.Pregabalin may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.Pregabalin may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.Nabumetone may decrease the excretion rate of Pregabalin which could result in a higher serum level.Pregabalin may increase the bradycardic activities of Nadolol.Pregabalin may decrease the excretion rate of Naldemedine which could result in a higher serum level.Pregabalin may decrease the excretion rate of Nalmefene which could result in a higher serum level.Pregabalin may decrease the excretion rate of Naloxone which could result in a higher serum level.Naproxen may decrease the excretion rate of Pregabalin which could result in a higher serum level.Pregabalin may increase the bradycardic activities of Nebivolol.Pregabalin may decrease the excretion rate of Nedocromil which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Pregabalin.Pregabalin may increase the bradycardic activities of Nicardipine.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Nifedipine.Pregabalin may decrease the excretion rate of Nilutamide which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Nimodipine.Pregabalin may increase the bradycardic activities of Nisoldipine.Pregabalin may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.Pregabalin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.Pregabalin may decrease the excretion rate of Nitroprusside which could result in a higher serum level.Pregabalin may decrease the excretion rate of Octinoxate which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Ofloxacin.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Olodaterol.Olsalazine may decrease the excretion rate of Pregabalin which could result in a higher serum level.Oseltamivir may decrease the excretion rate of Pregabalin which could result in a higher serum level.Pregabalin may decrease the excretion rate of Oxacillin which could result in a higher serum level.Oxaprozin may decrease the excretion rate of Pregabalin which could result in a higher serum level.Pregabalin may decrease the excretion rate of Oxybenzone which could result in a higher serum level.Pregabalin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Pregabalin.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Pacritinib.Pamidronic acid may decrease the excretion rate of Pregabalin which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Panobinostat.Pantoprazole may decrease the excretion rate of Pregabalin which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Papaverine.Parecoxib may decrease the excretion rate of Pregabalin which could result in a higher serum level.Paromomycin may decrease the excretion rate of Pregabalin which could result in a higher serum level.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Pasireotide.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Pazopanib.The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Pregabalin.Pregabalin may decrease the excretion rate of Pentetic acid which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Perflutren.Pregabalin may decrease the excretion rate of Permethrin which could result in a higher serum level.Phenazopyridine may decrease the excretion rate of Pregabalin which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Pheniramine.Pregabalin may decrease the excretion rate of Phosphoric acid which could result in a higher serum level.Pregabalin may decrease the excretion rate of Phylloquinone which could result in a higher serum level.Pregabalin may decrease the excretion rate of Picosulfuric acid which could result in a higher serum level.Pregabalin may increase the bradycardic activities of Pinaverium.The risk or severity of weight gain and edema formation can be increased when Pregabalin is combined with Pioglitazone.Pregabalin may decrease the excretion rate of Piperacillin which could result in a higher serum level.Piroxicam may decrease the excretion rate of Pregabalin which could result in a higher serum level.Pregabalin may decrease the excretion rate of Plerixafor which could result in a higher serum level.Polythiazide may increase the excretion rate of Pregabalin which could result in a lower serum level and potentially a reduction in efficacy.Pregabalin may increase the bradycardic activities of Poractant alfa.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Posaconazole.Potassium may increase the excretion rate of Pregabalin which could result in a lower serum level and potentially a reduction in efficacy.Pregabalin may decrease the excretion rate of Potassium acetate which could result in a higher serum level.Pregabalin may decrease the excretion rate of Potassium bicarbonate which could result in a higher serum level.Pregabalin may decrease the excretion rate of Potassium cation which could result in a higher serum level.Pregabalin may decrease the excretion rate of Potassium chloride which could result in a higher serum level.Potassium citrate may increase the excretion rate of Pregabalin which could result in a lower serum level and potentially a reduction in efficacy.Pregabalin may decrease the excretion rate of Potassium nitrate which could result in a higher serum level.Pregabalin may decrease the excretion rate of Potassium sulfate which could result in a higher serum level.Pregabalin may decrease the excretion rate of Pralatrexate which could result in a higher serum level.Pregabalin may decrease the excretion rate of Pralidoxime which could result in a higher serum level.Pregabalin may decrease the excretion rate of Prasugrel which could result in a higher serum level.Pregabalin may decrease the excretion rate of Prednisone which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Primaquine.Pregabalin may decrease the excretion rate of Probenecid which could result in a higher serum level.Pregabalin may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Propafenone.Pregabalin may decrease the excretion rate of Propantheline which could result in a higher serum level.Pregabalin may increase the bradycardic activities of Propranolol.Propyphenazone may decrease the excretion rate of Pregabalin which could result in a higher serum level.Pregabalin may decrease the excretion rate of Prucalopride which could result in a higher serum level.Pregabalin may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.Pyridoxine may decrease the excretion rate of Pregabalin which could result in a higher serum level.Pregabalin may decrease the excretion rate of Rabeprazole which could result in a higher serum level.Pregabalin may decrease the excretion rate of Ranitidine which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Ranolazine.Pregabalin may increase the bradycardic activities of Regorafenib.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Relugolix.Pregabalin may decrease the excretion rate of Resorcinol which could result in a higher serum level.Pregabalin may decrease the excretion rate of Ribavirin which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Rilpivirine.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Ritonavir.Pregabalin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.Pregabalin may increase the bradycardic activities of Rivastigmine.Pregabalin may decrease the excretion rate of Rizatriptan which could result in a higher serum level.Pregabalin may decrease the excretion rate of Roflumilast which could result in a higher serum level.The risk or severity of weight gain and edema formation can be increased when Pregabalin is combined with Rosiglitazone.Salicylamide may decrease the excretion rate of Pregabalin which could result in a higher serum level.Salicylic acid may decrease the excretion rate of Pregabalin which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Salmeterol.Salmon calcitonin may decrease the excretion rate of Pregabalin which could result in a higher serum level.Salsalate may decrease the excretion rate of Pregabalin which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Saquinavir.Pregabalin may decrease the excretion rate of Selenious acid which could result in a higher serum level.Pregabalin may decrease the excretion rate of Selenium which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Selpercatinib.Pregabalin may decrease the excretion rate of Sodium acetate which could result in a higher serum level.Pregabalin may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.Pregabalin may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.Pregabalin may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Solifenacin.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Sorafenib.Pregabalin may decrease the excretion rate of Sorbitol which could result in a higher serum level.Spironolactone may increase the excretion rate of Pregabalin which could result in a lower serum level and potentially a reduction in efficacy.Pregabalin may decrease the excretion rate of Sucralfate which could result in a higher serum level.Pregabalin may decrease the excretion rate of Sulbactam which could result in a higher serum level.Sulfasalazine may decrease the excretion rate of Pregabalin which could result in a higher serum level.Sulindac may decrease the excretion rate of Pregabalin which could result in a higher serum level.Pregabalin may decrease the excretion rate of Synthetic Conjugated Estrogens, A which could result in a higher serum level.Pregabalin may decrease the excretion rate of Synthetic Conjugated Estrogens, B which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Tacrolimus.Pregabalin may decrease the excretion rate of Tadalafil which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Tamoxifen.Pregabalin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.Pregabalin may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.Pregabalin may decrease the excretion rate of Technetium Tc-99m pyrophosphate which could result in a higher serum level.Pregabalin may decrease the excretion rate of Teduglutide which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Telavancin.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Telithromycin.Pregabalin may decrease the excretion rate of Temozolomide which could result in a higher serum level.Tenofovir disoproxil may decrease the excretion rate of Pregabalin which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Terbutaline.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Terlipressin.Pregabalin may decrease the excretion rate of Testosterone which could result in a higher serum level.Pregabalin may decrease the excretion rate of Testosterone cypionate which could result in a higher serum level.Pregabalin may decrease the excretion rate of Testosterone propionate which could result in a higher serum level.Pregabalin may decrease the excretion rate of Testosterone undecanoate which could result in a higher serum level.Pregabalin may decrease the excretion rate of Tetracycline which could result in a higher serum level.Pregabalin may decrease the excretion rate of Tetradecyl hydrogen sulfate (ester) which could result in a higher serum level.Ticlopidine may decrease the excretion rate of Pregabalin which could result in a higher serum level.Pregabalin may increase the bradycardic activities of Timolol.Pregabalin may decrease the excretion rate of Tinidazole which could result in a higher serum level.Pregabalin may decrease the excretion rate of Tiopronin which could result in a higher serum level.Pregabalin may decrease the excretion rate of Tiotropium which could result in a higher serum level.Pregabalin may decrease the excretion rate of Tirofiban which could result in a higher serum level.Pregabalin may decrease the excretion rate of Tixocortol which could result in a higher serum level.Pregabalin may decrease the excretion rate of Tocopherol which could result in a higher serum level.Pregabalin may increase the bradycardic activities of Tofacitinib.Tolmetin may decrease the excretion rate of Pregabalin which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Tolterodine.Tolvaptan may increase the excretion rate of Pregabalin which could result in a lower serum level and potentially a reduction in efficacy.Torasemide may increase the excretion rate of Pregabalin which could result in a lower serum level and potentially a reduction in efficacy.Pregabalin may decrease the excretion rate of Trametinib which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Treprostinil.Triamterene may decrease the excretion rate of Pregabalin which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Triclabendazole.Pregabalin may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.Pregabalin may decrease the excretion rate of Trifluridine which could result in a higher serum level.Pregabalin may decrease the excretion rate of Trimethoprim which could result in a higher serum level.Pregabalin may decrease the excretion rate of Trimetrexate which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Triptorelin.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Ubidecarenone.Pregabalin may decrease the excretion rate of Vaborbactam which could result in a higher serum level.Valaciclovir may decrease the excretion rate of Pregabalin which could result in a higher serum level.Pregabalin may decrease the excretion rate of Valbenazine which could result in a higher serum level.Valdecoxib may decrease the excretion rate of Pregabalin which could result in a higher serum level.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Vardenafil.Pregabalin may decrease the excretion rate of Varenicline which could result in a higher serum level.Pregabalin may increase the bradycardic activities of Verapamil.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Voriconazole.The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Vorinostat.Pregabalin may decrease the excretion rate of Zanamivir which could result in a higher serum level.
A therapy excluded from this list of known interactions does not necessarily mean that no interactions exist between that therapy and and Lyrica®.
Azelastine
Clonidine
Ethanol
Hydroxychloroquine
Hydroxyzine
Lefamulin
Lorazepam
Methadone
Oliceridine
Oxycodone
Ponesimod
Sodium oxybate
Thalidomide
Trazodone
Ziprasidone
Acarbose
Acetazolamide
Acetylsalicylic acid
Alfentanil
Almotriptan
Alogliptin
Alosetron
Alprazolam
Alteplase
Amikacin
Aminophylline
Amiodarone
Amisulpride
Amitriptyline
Amobarbital
Amoxapine
Amphetamine
Amphotericin B
Anagrelide
Apomorphine
Aripiprazole
Aripiprazole lauroxil
Arsenic trioxide
Artemether
Articaine
Asenapine
Atracurium besylate
Azilsartan medoxomil
Baclofen
Bedaquiline
Benazepril
Benzhydrocodone
Benzocaine
Benzphetamine
Benzyl alcohol
Bexagliflozin
Borage oil
Botulinum toxin type B
Brexanolone
Brexpiprazole
Brimonidine
Brivaracetam
Bromocriptine
Bromotheophylline
Brompheniramine
Bupivacaine
Buprenorphine
Bupropion
Buspirone
Butalbital
Butamben
Butorphanol
Cabergoline
Caffeine
Canagliflozin
Cannabidiol
Capreomycin
Capsaicin
Captopril
Carbinoxamine
Cariprazine
Carisoprodol
Cefotaxime
Centella asiatica
Ceritinib
Cetirizine
Chlorambucil
Chlordiazepoxide
Chloroprocaine
Chloroquine
Chlorpheniramine
Chlorpromazine
Chlorzoxazone
Cinchocaine
Cisatracurium
Cisplatin
Citalopram
Clemastine
Clidinium
Clobazam
Clomipramine
Clonazepam
Clorazepic acid
Clozapine
Cocaine
Codeine
Colistin
Conjugated estrogens
Crizotinib
Cyclobenzaprine
Cyclosporine
Cyproheptadine
Dantrolene
Dapagliflozin
Daridorexant
Desflurane
Desipramine
Desloratadine
Desogestrel
Desvenlafaxine
Deutetrabenazine
Dexbrompheniramine
Dexchlorpheniramine maleate
Dexmedetomidine
Dexmethylphenidate
Dextromethorphan
Dextropropoxyphene
Diazepam
Diclofenac
Dienogest
Diethylpropion
Difenoxin
Digoxin
Dihydrocodeine
Dihydroergotamine
Dimenhydrinate
Diphenhydramine
Diphenoxylate
Disopyramide
Disulfiram
Dofetilide
Dolasetron
Donepezil
Doxepin
Doxylamine
Dronabinol
Dronedarone
Droperidol
Drospirenone
Dulaglutide
Duloxetine
Dyclonine
Efavirenz
Eletriptan
Eliglustat
Eluxadoline
Empagliflozin
Enalapril
Enalaprilat
Encorafenib
Entacapone
Entrectinib
Epinastine
Eprosartan
Ergotamine
Erlotinib
Ertugliflozin
Escitalopram
Esketamine
Eslicarbazepine acetate
Estazolam
Estetrol
Estradiol
Estradiol cypionate
Estradiol valerate
Estrone sulfate
Eszopiclone
Ethinylestradiol
Ethosuximide
Ethotoin
Ethynodiol diacetate
Etomidate
Etonogestrel
Etrasimod
Evening primrose oil
Exenatide
Felbamate
Fenfluramine
Fentanyl
Fexinidazole
Flibanserin
Fluoxetine
Fluphenazine
Flurazepam
Fluticasone propionate
Fluvoxamine
Fosinopril
Fosphenytoin
Frovatriptan
Gabapentin
Gabapentin enacarbil
gamma-Hydroxybutyric acid
Ganaxolone
Ganciclovir
Gentamicin
Gepirone
Gepotidacin
Gestodene
Givinostat
Glasdegib
Glimepiride
Glipizide
Glyburide
Granisetron
Guanfacine
Haloperidol
Hydrocodone
Hydromorphone
Hydroxyprogesterone caproate
Ibuprofen
Ibutilide
Icatibant
Iloperidone
Imatinib
Imipenem
Imipramine
Inotuzumab ozogamicin
Insulin aspart
Insulin degludec
Insulin detemir
Insulin glargine
Insulin glulisine
Insulin human
Insulin lispro
Iohexol
Isocarboxazid
Isoflurane
Isoniazid
Isosorbide mononitrate
Ketamine
Lasmiditan
Lemborexant
Levetiracetam
Levocabastine
Levocetirizine
Levodopa
Levomilnacipran
Levonorgestrel
Levorphanol
Lidocaine
Linagliptin
Linezolid
Liraglutide
Lisinopril
Lithium carbonate
Lixisenatide
Lofexidine
Losartan
Loxapine
Lumateperone
Lumefantrine
Lurasidone
Macimorelin
Magnesium sulfate
Maprotiline
Mecasermin
Meclizine
Medroxyprogesterone acetate
Mefloquine
Megestrol acetate
Melatonin
Meloxicam
Meperidine
Mepivacaine
Meprobamate
Mepyramine
Mercaptopurine
Metaxalone
Metformin
Methocarbamol
Methohexital
Methsuximide
Methylene blue
Methylphenidate
Metoclopramide
Metronidazole
Metyrosine
Midazolam
Mifepristone
Miglitol
Milnacipran
Mirtazapine
Moexipril
Molindone
Morphine
Nabilone
Nalbuphine
Naloxegol
Naltrexone
Naphazoline
Naratriptan
Nateglinide
Nefazodone
Neomycin
Nilotinib
Nitrous oxide
Nonoxynol-9
Norelgestromin
Norethisterone
Norgestimate
Norgestrel
Nortriptyline
Octreotide
Olanzapine
Ondansetron
Opium
Orlistat
Orphenadrine
Oxaliplatin
Oxazepam
Oxcarbazepine
Oxybuprocaine
Oxymorphone
Paliperidone
Palonosetron
Pancuronium
Paroxetine
Pemetrexed
Pentamidine
Pentazocine
Pentobarbital
Pentostatin
Pentoxifylline
Perampanel
Pergolide
Perindopril
Perphenazine
Phenelzine
Phenol
Pimavanserin
Pimozide
Pindolol
Pitolisant
Plazomicin
Pomalidomide
Pramipexole
Pramlintide
Pramocaine
Prilocaine
Primidone
Procainamide
Procaine
Procarbazine
Prochlorperazine
Progesterone
Promethazine
Proparacaine
Propofol
Protriptyline
Pyrantel
Quazepam
Quetiapine
Quinapril
Quinidine
Quinine
Quizartinib
Ramelteon
Ramipril
Rasagiline
Remifentanil
Remimazolam
Repaglinide
Reserpine
Revumenib
Ribociclib
Riluzole
Risperidone
Rocuronium
Romidepsin
Ropeginterferon alfa-2b
Ropinirole
Ropivacaine
Rotigotine
Rufinamide
Ruxolitinib
Sacubitril
Safinamide
Sage oil
Samidorphan
Saxagliptin
Scopolamine
Secobarbital
Segesterone acetate
Selegiline
Semaglutide
Sertraline
Sevoflurane
Sirolimus
Sitagliptin
Sodium phosphate, monobasic
Solriamfetol
Sotagliflozin
Sotalol
Stiripentol
Streptomycin
Succinylcholine
Sufentanil
Sulfadiazine
Sulfamethoxazole
Sumatriptan
Sunitinib
Suvorexant
Tapentadol
Tasimelteon
Telmisartan
Temazepam
Temsirolimus
Tenecteplase
Tenofovir alafenamide
Testosterone enanthate
Tetrabenazine
Tetracaine
Tetracosactide
Theophylline
Thioridazine
Thiothixene
Tiagabine
Tirzepatide
Tizanidine
Tobramycin
Tolazamide
Tolcapone
Topotecan
Toremifene
Trandolapril
Tranylcypromine
Triazolam
Trifluoperazine
Trimethobenzamide
Trimipramine
Triprolidine
Trovafloxacin
Tryptophan
Ulipristal
Urokinase
Valganciclovir
Valsartan
Vancomycin
Vandetanib
Vecuronium
Vemurafenib
Venlafaxine
Vigabatrin
Vilanterol
Vilazodone
Viloxazine
Vortioxetine
Warfarin
Zaleplon
Ziconotide
Zolmitriptan
Zolpidem
Zonisamide
Zuranolone
Abacavir
Acebutolol
Aceclofenac
Acetaminophen
Aclidinium
Acrivastine
Acyclovir
Adagrasib
Adefovir dipivoxil
Adenosine
Albuterol
Albutrepenonacog alfa
Alcaftadine
Aldesleukin
Alfuzosin
Allopurinol
Almasilate
Amantadine
Amifampridine
Amiloride
Amlodipine
Ammonium chloride
Amoxicillin
Ampicillin
Antipyrine
Antithrombin III human
Apalutamide
Apremilast
Arformoterol
Atazanavir
Atenolol
Atomoxetine
Atropine
Auranofin
Azacitidine
Azathioprine
Azelaic acid
Azithromycin
Aztreonam
Bacitracin
Balsalazide
Baricitinib
Bendroflumethiazide
Benzatropine
Benzgalantamine
Benznidazole
Bepotastine
Beractant
Berotralstat
Besifloxacin
Betaxolol
Bicisate
Bismuth subgallate
Bisoprolol
Bleomycin
Bortezomib
Bretylium
Budesonide
Bumetanide
Calfactant
Capecitabine
Carbidopa
Carboplatin
Carmustine
Carteolol
Carvedilol
Cefaclor
Cefadroxil
Cefazolin
Cefdinir
Cefditoren
Cefepime
Cefotetan
Cefoxitin
Cefpodoxime
Cefprozil
Ceftaroline fosamil
Ceftazidime
Ceftibuten
Ceftizoxime
Ceftolozane
Ceftriaxone
Cefuroxime
Celecoxib
Cephalexin
Certolizumab pegol
Cevimeline
Chlorcyclizine
Chlorothiazide
Chlorthalidone
Choline salicylate
Chondroitin sulfate
Chromic chloride
Chromium
Chromium nicotinate
Cidofovir
Cilostazol
Cimetidine
Ciprofloxacin
Clarithromycin
Clevidipine
Clofarabine
Clove oil
Colchicine
Colistimethate
Conivaptan
Dabigatran etexilate
Dabrafenib
Dacarbazine
Dalfampridine
Daptomycin
Dasatinib
DaxibotulinumtoxinA
Deferiprone
Degarelix
Delafloxacin
Desmopressin
Dexpanthenol
Dexrazoxane
Dextran
Diatrizoate
Diclofenamide
Dicyclomine
Didanosine
Diflunisal
Diltiazem
Dimercaprol
Dimethyl sulfoxide
DL-Methylephedrine
Dobutamine
Dopamine
Doxycycline
Droxidopa
Echothiophate
Edoxaban
Edrophonium
Emedastine
Enzalutamide
Eplerenone
Epoprostenol
Eribulin
Ertapenem
Erythromycin
Esmolol
Estradiol acetate
Etacrynic acid
Ethambutol
Ethenzamide
Etodolac
Eucalyptus oil
Famotidine
Felodipine
Fenofibrate
Fenofibric acid
Fenoldopam
Fenoprofen
Fesoterodine
Finerenone
Fingolimod
Flavoxate
Flecainide
Florbetaben F-18
Florbetapir F-18
Floxuridine
Fluconazole
Flucytosine
Fludeoxyglucose (18F)
Flumazenil
Fluocinolone acetonide
Fluorouracil
Flurbiprofen
Flutamide
Folic acid
Fomepizole
Fondaparinux
Formoterol
Foscarnet
Fosfomycin
Fostemsavir
Furosemide
Gadobenic acid
Gadodiamide
Gadofosveset trisodium
Gadoteric acid
Gadoteridol
Galantamine
Gatifloxacin
Gemcitabine
Gemfibrozil
Gemifloxacin
Gilteritinib
Givosiran
Glycerol phenylbutyrate
Golodirsen
Goserelin
Histrelin
Hydralazine
Hydrochlorothiazide
Hydroflumethiazide
Hydroxocobalamin
Hydroxyethyl Starch
Hyoscyamine
Ibandronate
Icosapent
Idarucizumab
Ifosfamide
Iloprost
Indapamide
Indigotindisulfonic acid
Indomethacin
Inositol
Inotersen
Iobenguane sulfate I-123
Iodixanol
Ioflupane I-123
Iopromide
Iothalamic acid
Ioversol
Ipecac
Ipilimumab
Isosorbide
Isosulfan blue
Isotretinoin
Isradipine
Itraconazole
Ivabradine
Ivosidenib
Ixazomib
Ketoconazole
Ketoprofen
Ketorolac
Labetalol
Lacosamide
Lamivudine
Landiolol
Lanreotide
Lapatinib
Ledipasvir
Lenalidomide
Lenvatinib
Leuprolide
Levocarnitine
Levofloxacin
Levoketoconazole
Levomenthol
Levosalbutamol
Liothyronine
Lipoic acid
Lithium citrate
Lomefloxacin
Loperamide
Lopinavir
Loratadine
Lubiprostone
Macitentan
Magnesium carbonate
Magnesium chloride
Magnesium hydroxide
Magnesium salicylate
Magnesium trisilicate
Malathion
Mannitol
Mavorixafor
Mecamylamine
Meclofenamic acid
Mefenamic acid
Memantine
Meropenem
Mesalazine
Metamfetamine
Methazolamide
Methimazole
Methotrexate
Methoxsalen
Methyldopa
Methylnaltrexone
Methyltestosterone
Metolazone
Metoprolol
Metyrapone
Midodrine
Migalastat
Milrinone
Minocycline
Mirabegron
Moxifloxacin
Mycophenolate mofetil
Mycophenolic acid
N-acetyltyrosine
Nabumetone
Nadolol
Naldemedine
Nalmefene
Naloxone
Naproxen
Nebivolol
Nedocromil
Nelfinavir
Nicardipine
Nifedipine
Nilutamide
Nimodipine
Nisoldipine
Nitric Oxide
Nitrofurantoin
Nitroprusside
Octinoxate
Ofloxacin
Olodaterol
Olsalazine
Oseltamivir
Oxacillin
Oxaprozin
Oxybenzone
Oxyquinoline
Oxytocin
Pacritinib
Pamidronic acid
Panobinostat
Pantoprazole
Papaverine
Parecoxib
Paromomycin
Pasireotide
Pazopanib
Pegvisomant
Pentetic acid
Perflutren
Permethrin
Phenazopyridine
Pheniramine
Phosphoric acid
Phylloquinone
Picosulfuric acid
Pinaverium
Pioglitazone
Piperacillin
Piroxicam
Plerixafor
Polythiazide
Poractant alfa
Posaconazole
Potassium
Potassium acetate
Potassium bicarbonate
Potassium cation
Potassium chloride
Potassium citrate
Potassium nitrate
Potassium sulfate
Pralatrexate
Pralidoxime
Prasugrel
Prednisone
Primaquine
Probenecid
Procaine benzylpenicillin
Propafenone
Propantheline
Propranolol
Propyphenazone
Prucalopride
Pyrazinamide
Pyridoxine
Rabeprazole
Ranitidine
Ranolazine
Regorafenib
Relugolix
Resorcinol
Ribavirin
Rilpivirine
Ritonavir
Rivaroxaban
Rivastigmine
Rizatriptan
Roflumilast
Rosiglitazone
Salicylamide
Salicylic acid
Salmeterol
Salmon calcitonin
Salsalate
Saquinavir
Selenious acid
Selenium
Selpercatinib
Sodium acetate
Sodium fluoride
Sodium sulfate
Sofosbuvir
Solifenacin
Sorafenib
Sorbitol
Spironolactone
Sucralfate
Sulbactam
Sulfasalazine
Sulindac
Synthetic Conjugated Estrogens, A
Synthetic Conjugated Estrogens, B
Tacrolimus
Tadalafil
Tamoxifen
Tamsulosin
Technetium Tc-99m exametazime
Technetium Tc-99m pyrophosphate
Teduglutide
Telavancin
Telithromycin
Temozolomide
Tenofovir disoproxil
Terbutaline
Terlipressin
Testosterone
Testosterone cypionate
Testosterone propionate
Testosterone undecanoate
Tetracycline
Tetradecyl hydrogen sulfate (ester)
Ticlopidine
Timolol
Tinidazole
Tiopronin
Tiotropium
Tirofiban
Tixocortol
Tocopherol
Tofacitinib
Tolmetin
Tolterodine
Tolvaptan
Torasemide
Trametinib
Treprostinil
Triamterene
Triclabendazole
Triethylenetetramine
Trifluridine
Trimethoprim
Trimetrexate
Triptorelin
Ubidecarenone
Vaborbactam
Valaciclovir
Valbenazine
Valdecoxib
Vardenafil
Varenicline
Verapamil
Voriconazole
Vorinostat
Zanamivir